• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Novo Nordisk, Eli Lilly face injury lawsuit from user of popular GLP-1 medicines

cafead

Administrator
Staff member
  • cafead   Aug 03, 2023 at 07:02: PM
via As Novo Nordisk and Eli Lilly rack up significant sales from their GLP-1 diabetes and obesity drugs, the companies also must gear up for defense against lawsuits from new users.

article source
 

<